Login
From:
Liver Disease News
(Uncensored)
subscribe
Roche to acquire 89bio, will get pegozafermin for MASH in deal
https://liverdiseasenews.com/news/roche-acquiring-89bio-getting-mash-therapy-candidate-pegozafermin/
links
backlinks
Tagged with:
news
fatty liver disease
Roche is acquiring 89bio and its fatty liver disease therapy candidate pegozafermin, being tested for MASH in two global clinical trials.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
